Cargando…

Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk

ESSENTIALS: VWF multimers have an established association with valvular heart disease. Significant interlaboratory variation exists in VWF multimeric analysis. We describe a method to normalize VWF multimers for assessment of cardiac lesion severity and clinical bleeding. Normalized VWF multimer rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Austin, Christopher O., Chen, Dong, Thomas, Colleen S., Safford, Robert E., Shapiro, Brian P., Bryan, Justin A., Ray, Jordan C., Blackshear, Joseph L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055563/
https://www.ncbi.nlm.nih.gov/pubmed/30046716
http://dx.doi.org/10.1002/rth2.12062
_version_ 1783341196464095232
author Austin, Christopher O.
Chen, Dong
Thomas, Colleen S.
Safford, Robert E.
Shapiro, Brian P.
Bryan, Justin A.
Ray, Jordan C.
Blackshear, Joseph L.
author_facet Austin, Christopher O.
Chen, Dong
Thomas, Colleen S.
Safford, Robert E.
Shapiro, Brian P.
Bryan, Justin A.
Ray, Jordan C.
Blackshear, Joseph L.
author_sort Austin, Christopher O.
collection PubMed
description ESSENTIALS: VWF multimers have an established association with valvular heart disease. Significant interlaboratory variation exists in VWF multimeric analysis. We describe a method to normalize VWF multimers for assessment of cardiac lesion severity and clinical bleeding. Normalized VWF multimer ratios improved the diagnostic capabilities of the assay. BACKGROUND: von Willebrand factor (VWF) multimer quantitation has been utilized in the assessment of valvular heart disease, however, there is no standardized method for quantitation. We compared three methods of assessment which utilized a normal plasma control. METHODS: We analyzed 476 samples and their control plasma from 368 patients with valvular heart disease, hypertrophic cardiomyopathy, or LVAD therapy, and 27 normal subjects. VWF multimers were assessed as normalized VWF multimer ratios (NMR) of gel bands >15/2‐15 (NMR15) or gel bands >10/2‐10 (NMR10). Associations of VWF laboratory and multimeric assessments with cardiac lesion severity and acquired bleeding were investigated. RESULTS: Abnormal multimers were present in 78% of patients with moderate to severe hemodynamic abnormalities compared to 19% of patients with normal or mildly abnormal hemodynamics. NMR showed strong association with severe cardiac lesions (NMR15: OR 15.29, CI 9.04‐27.18; NMR10: OR 14.18, CI 8.88‐23.21). PFA‐CADP was strongly associated with moderate to severe cardiac lesions (OR 14.91, CI 9.08‐24.50). PFA‐CADP and NMR15 showed excellent ability to discriminate ≥moderate (AUC 0.86, CI 0.83‐0.89 and 0.83, CI 0.79‐0.87 respectively) and severe cardiac lesions (AUC 0.84, CI 0.81‐0.88 and 0.85, CI 0.81‐0.88 respectively). NMR was less strongly associated with bleeding (OR 4.01 for NMR10, CI 2.49‐6.58). CONCLUSION: Quantification of VWF multimers may provide clinical utility in circumstances where clinical estimation of cardiac lesion severity is challenging, such as with dysfunctional prosthetic valves. The presence of abnormal VWF multimers is associated with bleeding, however further quantitation provided only modest improvement in risk stratification.
format Online
Article
Text
id pubmed-6055563
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60555632018-07-25 Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk Austin, Christopher O. Chen, Dong Thomas, Colleen S. Safford, Robert E. Shapiro, Brian P. Bryan, Justin A. Ray, Jordan C. Blackshear, Joseph L. Res Pract Thromb Haemost Original Articles: Haemostasis ESSENTIALS: VWF multimers have an established association with valvular heart disease. Significant interlaboratory variation exists in VWF multimeric analysis. We describe a method to normalize VWF multimers for assessment of cardiac lesion severity and clinical bleeding. Normalized VWF multimer ratios improved the diagnostic capabilities of the assay. BACKGROUND: von Willebrand factor (VWF) multimer quantitation has been utilized in the assessment of valvular heart disease, however, there is no standardized method for quantitation. We compared three methods of assessment which utilized a normal plasma control. METHODS: We analyzed 476 samples and their control plasma from 368 patients with valvular heart disease, hypertrophic cardiomyopathy, or LVAD therapy, and 27 normal subjects. VWF multimers were assessed as normalized VWF multimer ratios (NMR) of gel bands >15/2‐15 (NMR15) or gel bands >10/2‐10 (NMR10). Associations of VWF laboratory and multimeric assessments with cardiac lesion severity and acquired bleeding were investigated. RESULTS: Abnormal multimers were present in 78% of patients with moderate to severe hemodynamic abnormalities compared to 19% of patients with normal or mildly abnormal hemodynamics. NMR showed strong association with severe cardiac lesions (NMR15: OR 15.29, CI 9.04‐27.18; NMR10: OR 14.18, CI 8.88‐23.21). PFA‐CADP was strongly associated with moderate to severe cardiac lesions (OR 14.91, CI 9.08‐24.50). PFA‐CADP and NMR15 showed excellent ability to discriminate ≥moderate (AUC 0.86, CI 0.83‐0.89 and 0.83, CI 0.79‐0.87 respectively) and severe cardiac lesions (AUC 0.84, CI 0.81‐0.88 and 0.85, CI 0.81‐0.88 respectively). NMR was less strongly associated with bleeding (OR 4.01 for NMR10, CI 2.49‐6.58). CONCLUSION: Quantification of VWF multimers may provide clinical utility in circumstances where clinical estimation of cardiac lesion severity is challenging, such as with dysfunctional prosthetic valves. The presence of abnormal VWF multimers is associated with bleeding, however further quantitation provided only modest improvement in risk stratification. John Wiley and Sons Inc. 2017-12-21 /pmc/articles/PMC6055563/ /pubmed/30046716 http://dx.doi.org/10.1002/rth2.12062 Text en © 2017 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles: Haemostasis
Austin, Christopher O.
Chen, Dong
Thomas, Colleen S.
Safford, Robert E.
Shapiro, Brian P.
Bryan, Justin A.
Ray, Jordan C.
Blackshear, Joseph L.
Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
title Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
title_full Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
title_fullStr Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
title_full_unstemmed Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
title_short Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
title_sort von willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
topic Original Articles: Haemostasis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055563/
https://www.ncbi.nlm.nih.gov/pubmed/30046716
http://dx.doi.org/10.1002/rth2.12062
work_keys_str_mv AT austinchristophero vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk
AT chendong vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk
AT thomascolleens vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk
AT saffordroberte vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk
AT shapirobrianp vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk
AT bryanjustina vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk
AT rayjordanc vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk
AT blackshearjosephl vonwillebrandfactormultimerquantitationforassessmentofcardiaclesionseverityandbleedingrisk